Heron Therapeutics, Inc. (NASDAQ:HRTX) Holdings Boosted by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. raised its position in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) by 0.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,105,803 shares of the biotechnology company’s stock after acquiring an additional 9,418 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Heron Therapeutics […]
